Identification and targeting of specific cellular pathways or markers that are amenable to intervention by senolytic peptides, which are molecules designed to selectively induce apoptosis in senescent cells. Senescent cells accumulate with age and secrete pro-inflammatory factors, contributing to systemic entropy. Targeting these cells is a key strategy in longevity science aimed at improving tissue function and overall healthspan. This is a focused application within regenerative endocrinology.
Origin
Senolytic is a portmanteau derived from senescence (aging) and lysis (destruction). Peptide targets refer to the specific molecular sites these therapeutic peptides are designed to interact with on the senescent cell surface or within its internal machinery.
Mechanism
The mechanism involves peptides binding to receptors or signaling molecules unique to senescent cells, often those involved in evading apoptosis, such as the p53 or p16 pathways. Upon binding, the peptide initiates a cascade leading to programmed cell death, clearing the dysfunctional cells from the tissue microenvironment. This removal reduces chronic inflammation, thereby improving the local hormonal signaling milieu.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.